本页面由Tiger Trade Technology Pte. Ltd.提供服务

Royalty Pharma plc

45.36
+0.21000.47%
成交量:257.36万
成交额:1.17亿
市值:264.53亿
市盈率:25.46
高:45.78
开:45.20
低:44.88
收:45.15
52周最高:46.14
52周最低:29.66
股本:5.83亿
流通股本:3.80亿
量比:0.83
换手率:0.68%
股息:0.88
股息率:1.94%
每股收益(TTM):1.78
每股收益(LYR):1.78
净资产收益率:13.20%
总资产收益率:5.15%
市净率:4.08
市盈率(LYR):25.46

数据加载中...

2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report